Outcome of Autologous Hematopoietic Stem Cell Transplantation in Refractory Multiple Myeloma

BACKGROUND: Despite the introduction of effective novel agents, the outcome of patients with refractory multiple myeloma remains poor, particularly those refractory to both proteasome inhibitors (PIs) and immunomodulatory agents (IMiDs). Limited data is available on the role of autologous hematopoie...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer
Main Authors: Veltri, Lauren W., Milton, Denái R., Delgado, Ruby, Shah, Nina, Patel, Krina, Nieto, Yago, Kebriaei, Partow, Popat, Uday R., Parmar, Simrit, Oran, Betul, Ciurea, Stefan, Hosing, Chitra, Lee, Hans C., Manasanch, Elisabet, Orlowski, Robert Z., Shpall, Elizabeth J., Champlin, Richard E., Qazilbash, Muzaffar H., Bashir, Qaiser
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5656242/
https://ncbi.nlm.nih.gov/pubmed/28513828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30770
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker